132 related articles for article (PubMed ID: 9401667)
1. Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat.
Riihioja P; Jaatinen P; Oksanen H; Haapalinna A; Heinonen E; Hervonen A
Alcohol; 1997; 14(6):537-44. PubMed ID: 9401667
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat.
Riihioja P; Jaatinen P; Oksanen H; Haapalinna A; Heinonen E; Hervonen A
Alcohol Clin Exp Res; 1997 Aug; 21(5):804-8. PubMed ID: 9267529
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure.
Riihioja P; Jaatinen P; Haapalinna A; Kiianmaa K; Hervonen A
Alcohol Clin Exp Res; 1999 Mar; 23(3):432-8. PubMed ID: 10195815
[TBL] [Abstract][Full Text] [Related]
4. Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine.
Jaatinen P; Riihioja P; Haapalinna A; Heinonen E; Kiianmaa K; Hervonen A
Alcohol; 1995; 12(5):439-46. PubMed ID: 8519439
[TBL] [Abstract][Full Text] [Related]
5. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist.
Kalso EA; Pöyhiä R; Rosenberg PH
Pharmacol Toxicol; 1991 Feb; 68(2):140-3. PubMed ID: 1677190
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.
Hoffman WE; Kochs E; Werner C; Thomas C; Albrecht RF
Anesthesiology; 1991 Aug; 75(2):328-32. PubMed ID: 1677549
[TBL] [Abstract][Full Text] [Related]
7. Mydriatic and antinociceptive effects of intrathecal dexmedetomidine in conscious rats.
Horváth G; Kovács M; Szikszay M; Benedek G
Eur J Pharmacol; 1994 Feb; 253(1-2):61-6. PubMed ID: 7912198
[TBL] [Abstract][Full Text] [Related]
8. Effects of ageing and intermittent ethanol exposure on rat locus coeruleus and ethanol-withdrawal symptoms.
Riihioja P; Jaatinen P; Haapalinna A; Kiianmaa K; Hervonen A
Alcohol Alcohol; 1999; 34(5):706-17. PubMed ID: 10528813
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
Weinger MB; Segal IS; Maze M
Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
[TBL] [Abstract][Full Text] [Related]
10. Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y.
Woldbye DP; Ulrichsen J; Haugbøl S; Bolwig TG
Alcohol Alcohol; 2002; 37(4):318-21. PubMed ID: 12107031
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy.
Mirski MA; Rossell LA; McPherson RW; Traystman RJ
Anesthesiology; 1994 Dec; 81(6):1422-8. PubMed ID: 7992911
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive properties of intrathecal dexmedetomidine in rats.
Fisher B; Zornow MH; Yaksh TL; Peterson BM
Eur J Pharmacol; 1991 Jan; 192(2):221-5. PubMed ID: 1674472
[TBL] [Abstract][Full Text] [Related]
14. Spinal and systemic action of the alpha 2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response.
Sabbe MB; Penning JP; Ozaki GT; Yaksh TL
Anesthesiology; 1994 May; 80(5):1057-72. PubMed ID: 7912480
[TBL] [Abstract][Full Text] [Related]
15. Ethanol antagonism by atipamezole on motor performance in mice.
Seppälä T; Idänpään-Heikkilä JJ; Strömberg C; Mattila MJ
Life Sci; 1994; 55(3):245-51. PubMed ID: 7911966
[TBL] [Abstract][Full Text] [Related]
16. The mechanical antihyperalgesic effect of intrathecally administered MPV-2426, a novel alpha2 -adrenoceptor agonist, in a rat model of postoperative pain.
Onttonen T; Pertovaara A
Anesthesiology; 2000 Jun; 92(6):1740-5. PubMed ID: 10839926
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats.
Meert TF; De Kock M
Anesthesiology; 1994 Sep; 81(3):677-88. PubMed ID: 7916547
[TBL] [Abstract][Full Text] [Related]
19. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
Hayashi Y; Guo TZ; Maze M
Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of ethanol withdrawal syndrome by extract of Hypericum perforatum in Wistar rats.
Coskun I; Tayfun Uzbay I; Ozturk N; Ozturk Y
Fundam Clin Pharmacol; 2006 Oct; 20(5):481-8. PubMed ID: 16968419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]